The ‘breakthrough’ to make cures for neurological diseases viable

London-based biotech Cranebio, which works on the delivery of RNA treatments, thinks it’s found a way…

Japan Lacks a ‘Viable Option’ for Retaliating to Trump’s Tariffs

After being smacked with double-digit percentage tariffs by a key ally, Japan finds itself with few…